HIMS is trading 4.3% down at $23.98 after announcing plans to issue $300 million of convertible senior notes due 2032.

  • Proceeds are intended to fund international expansion, including the company's proposed Eucalyptus acquisition.
  • Investors often view convertible offerings as dilutive, which is weighing on the stock following recent volatility tied to its GLP-1 strategy shift.